NATIONAL STEEL CO (SID): what the price assumes

boothcheck covers NATIONAL STEEL CO (SID) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/SID

Headline

FieldValue
TickerSID
CompanyNATIONAL STEEL CO
Current price$0.98/sh
CompositionSteel 49% / Mining 34% / Logistics - Port 1% / Logistics - Railroads 7% / Logistics - Road transport 2% / Energy 2% / Cement 11% / Corporate expenses/elimination -6%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)4.7%
Operating margin today9.8%
Margin compression (value-band)-5.1pp
Multiple paid8x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 4.4% sits below it).

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.32σ
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.45x2justifies
Earnings0.08x2justifies
Relative0.10x3justifies
Growth0.34x4justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.

Per-Model Detail (n=11)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$18.680.05xyesFCF base $0.6B, growth 13% (input: historical growth), terminal g 4.0%, WACC 9.3%, 5yr projection
DCF Exit MultipleGrowth$7.490.13xyesExit EV/EBITDA: 4.0x / 0.0x / 5.0x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$9.690.10xyesP/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus
Simple DDMGrowth$1.760.56xyesDPS $0.37, g=-9.9% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$-1.17noStage 1: -174% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$2.290.43xyesReference only (book value floor): BV/sh $2.29, ROE negative
Two-Stage Excess ReturnAsset$2.060.48xyesReference only (book value with convergence): BV/sh $2.29, ROE converges to ke
Discounted Future Market CapGrowth$1.190.83xyesRev $8.6B, growth 13% (input: historical growth; tapered), Terminal P/S: 0.1x / 0.2x / 0.2x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$18.600.05xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.70B × (1−21%) / WACC 9.3% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelative$8.500.12xyesEBITDA $0.84B × sector EV/EBITDA 8.0x
FCF YieldEarnings$8.490.12xyesFCF $618.9M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$9.690.10xyesRevenue $8.57B × sector P/S 1.5x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$6.3b
Net debt / NOPAT (after-tax)9.69x
Net debt / operating income (pre-tax)7.66x
Interest coverage0.6x
Burning cashno

Bullet Takeaways

Bull Case

Steel ADRs trading near a dollar invite a reflexive dismissal, but the way to read CSN is through what the conglomerate actually owns rather than the price tag on the depositary receipt. This is one of Brazil's largest steel producers, the country's second-largest iron ore exporter, and its second-largest cement player, with a logistics arm bolted on. The first quarter of 2026 is the clearest proof that the mix matters: net revenue came in at R$10.6 billion and the company posted a net loss of R$555 million, yet adjusted EBITDA still reached R$2.65 billion at a 23.9% margin, driven by record cement performance and strength in logistics even as mining and construction demand weakened seasonally. A pure steelmaker would have had no offset; the diversified base did.

The valuation math is where the asset support shows. At today's price the market is paying roughly 8 times company-wide operating income, a multiple so low that the price sits below what even a 5%-a-year decline in operating profit would warrant. This is a value and asset-supported name, not a growth bet: the asset-value, earnings-power, relative-multiple and even the cash-flow methods all land at or above the price, which is the opposite pattern from a stock priced on hope. The current operating margin near 20.7% is real cash generation, not a turnaround promise, and the iron ore and cement franchises are tangible assets with replacement value rather than goodwill.

The forward case rests entirely on the capital structure healing. Management launched a 2026 deleveraging plan to divest selected assets and cut leverage by roughly R$16 to R$18 billion, targeting net debt at 1.8 times EBITDA, and it framed a longer arc in which a renewed portfolio centered on high-return mining, logistics and energy could roughly double EBITDA over about eight years while holding leverage near one time. The mining guidance gives the lever a number: 45 to 47 million tons of iron ore at a C1 cash cost of $22.0 to $23.5 per ton, with the P15 project ramping. If the asset sales close and the balance sheet repairs, the equity is the most levered way to play it.

Bear Case

Steel and iron ore are cyclical, and the bear case starts with where CSN sits in the cycle rather than with the cheap multiple. The first quarter of 2026 showed the strain plainly: net revenue fell 7.0% sequentially and 2.8% year over year, and the company posted a net loss of R$555 million. The EBITDA that held up did so on cement and logistics; the steel and mining cash engines, the parts that define a steel ADR, are running into soft demand and seasonal weakness. Trailing operating profit can look healthy at the top of a cycle and evaporate at the bottom, and a 20.7% operating margin in a commodity business is not a margin to extrapolate.

The balance sheet is the dominant risk and it is severe. The group closed the first quarter of 2026 with net debt of R$40.5 billion and net debt at 3.36 times trailing EBITDA, a level that leaves little room if the cycle turns down. Interest coverage of under two times means a large share of operating profit goes to servicing debt before any of it reaches an equity holder, and the ADR fell 22.5% in the first quarter alone. The entire deleveraging plan, R$16 to R$18 billion of asset sales targeting 1.8 times leverage, is an admission that the current structure is unsustainable; a plan to sell assets in a soft commodity market is a plan that depends on buyers paying full value at exactly the wrong time. There is no dividend, so a holder is not paid to wait.

This is why a price below what even a declining-profit scenario would warrant is not automatically a bargain. The price is supported by asset and earnings-power value on paper, but that support assumes the assets are worth their carrying value and the debt gets refinanced on acceptable terms. For a highly leveraged Brazilian commodity producer, both assumptions carry real risk: refinancing depends on credit markets and the real-to-dollar exchange rate, and an asset-supported floor only holds if the company is not forced to sell into weakness. The equity at a dollar is a call on a successful deleveraging; if the asset sales stall or come in light, the debt sits ahead of the equity in line.

Valuation

The price is making an unusual bet for a stock this cheap: almost none. At today's level the market pays roughly 8 times company-wide operating income, a multiple so low that the price sits below what even a 5%-a-year decline in operating profit would warrant. That is the bound, not a solved growth rate. The market is not asking CSN to grow; it is pricing the equity as if the operating profit erodes from here, which is a posture of distress rather than expectation.

The valuation lenses agree the price is asset and earnings supported. The asset-value methods, which lean on book value and tangible plant, land above the price; the earnings-power methods, which capitalize current operating profit, land furthest above; peer multiples and the cash-flow methods both sit above as well. When every family reaches or exceeds the price, the question stops being whether the business is too expensive and becomes whether the asset and earnings figures the methods rest on are real and collectible.

Solvency is where the analysis has to end, because it dominates everything else here. Net debt of R$40.5 billion at 3.36 times trailing EBITDA and interest coverage under two times mean the capital structure, not the operating business, sets the value of the equity. The methods value the enterprise; the debt has the first claim on it, and what reaches the equity is the residual after a large, expensive debt load is served. The 2026 plan to cut leverage by R$16 to R$18 billion toward 1.8 times is the variable that decides whether the asset-supported floor is a floor at all. Until those sales close, the cheap multiple describes a distressed balance sheet, not a discounted business.

Catalysts

CSN reported first-quarter 2026 results on May 13, 2026, with net revenue of R$10.6 billion, down 7.0% sequentially and 2.8% year over year, and a net loss of R$555 million that was nonetheless an improvement over both the prior quarter and the year-ago period. Adjusted EBITDA of R$2.65 billion at a 23.9% margin came from record cement performance and logistics strength offsetting seasonal weakness in mining and construction. The ADR declined 22.5% over the quarter.

The deleveraging plan is the defining catalyst for 2026. Announced in January 2026, it aims to divest selected assets to cut leverage by roughly R$16 to R$18 billion and rebalance the capital structure toward a growth cycle in mining and infrastructure, with a target of 1.8 times net debt to EBITDA. Each asset sale and refinancing step through the year is a discrete event that moves the equity, because the equity value is so tightly bound to the debt outcome. The group closed the first quarter at 3.36 times leverage, so the gap to the target is large and the execution risk is real.

On operations, management narrowed its 2026 mining outlook on March 11, 2026, guiding combined iron ore production and third-party purchases to 45 to 47 million tons and setting a 2026 mining C1 cash cost range of $22.0 to $23.5 per ton. The longer-term framing management has offered is a portfolio centered on high-return mining, logistics and energy assets, with the stated potential to roughly double EBITDA over about eight years while holding leverage near one time as projects like the P15 iron ore ramp-up come online. Iron ore and steel prices, and the real-to-dollar exchange rate, sit underneath all of it.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

CSN 1Q26 results, May 13 2026 · CSN deleveraging plan, January 2026 · CSN material fact, March 11 2026

View the full interactive SID report on boothcheck